Stay updated on ABI-009 for Epilepsy: Clinical Trial
Sign up to get notified when there's something new on the ABI-009 for Epilepsy: Clinical Trial page.

Latest updates to the ABI-009 for Epilepsy: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of a phase 1 study on ABI-009 for surgically-refractory epilepsy, while adding new collaborators and a revision number. The study's focus on the safety and efficacy of ABI-009 in a specific patient population has been largely deleted.SummaryDifference56%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to ABI-009 for Epilepsy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABI-009 for Epilepsy: Clinical Trial page.